ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,611.60
      1.25%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Immupharma Plc (IMM)

      7. Immupharma Plc (IMM) News

      IMM

      Immupharma (IMM)

      Immupharma Plc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:IMM
      DateTimeSourceHeadlineSymbolCompany
      09/26/20172:00AMUK RegulatoryImmupharma PLC Preparation of Lupuzor'sT Regulatory SubmissionsLSE:IMMImmupharma Plc
      09/21/20175:57AMAlliance NewsAlliance NewsImmupharma Confident As Phase III Lupuzor Trial On TrackLSE:IMMImmupharma Plc
      09/21/20172:00AMUK RegulatoryImmupharma PLC Update on LupuzorT Pivotal Phase III StudyLSE:IMMImmupharma Plc
      09/19/20172:01AMUK RegulatoryImmupharma PLC Notification of Interim ResultsLSE:IMMImmupharma Plc
      08/18/201712:09PMUK RegulatoryImmupharma PLC AIM Rule 17 NoticeLSE:IMMImmupharma Plc
      07/12/20176:00AMUK RegulatoryImmupharma PLC Grant of OptionsLSE:IMMImmupharma Plc
      06/30/20177:04AMUK RegulatoryImmupharma PLC Result of AGMLSE:IMMImmupharma Plc
      06/30/20176:49AMAlliance NewsAlliance NewsImmuPharma Recruits And Doses 200 Patients In Phase III Lupuzor TrialLSE:IMMImmupharma Plc
      06/30/20172:00AMUK RegulatoryImmupharma PLC Update on LupuzorT Pivotal Phase III StudyLSE:IMMImmupharma Plc
      06/07/20172:01AMUK RegulatoryImmupharma PLC Annual Report & Notice of AGMLSE:IMMImmupharma Plc
      06/01/20176:05AMAlliance NewsAlliance NewsImmuPharma 2016 Loss Widens As It Progresses Lupus Phase III TrialLSE:IMMImmupharma Plc
      06/01/20172:00AMUK RegulatoryImmupharma PLC Final ResultsLSE:IMMImmupharma Plc
      05/22/20172:01AMUK RegulatoryImmupharma PLC Notification of Full Year ResultsLSE:IMMImmupharma Plc
      05/17/20174:30AMAlliance NewsAlliance NewsImmuPharma On Track For Lupuzor Top-Line Data In First Quarter 2018LSE:IMMImmupharma Plc
      05/17/20172:00AMUK RegulatoryImmupharma PLC Update on Lupuzor Phase III StudyLSE:IMMImmupharma Plc
      03/31/20175:17AMUK RegulatoryImmupharma PLC New Employee Share Option Plan & Grant of OptionsLSE:IMMImmupharma Plc
      03/31/20173:33AMUK RegulatoryImmupharma PLC New Employee Share Option Plan & Grant of OptionsLSE:IMMImmupharma Plc
      03/24/20173:01AMRNS Non-RegulatoryImmupharma PLC ImmuPharma to present at Master Investor ShowLSE:IMMImmupharma Plc
      03/22/20174:51AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      03/20/20177:41AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      03/20/20176:51AMAlliance NewsAlliance NewsLegal & General Raises Stake In ImmuPharma To 3.4% In Funding Round (ALLISS)LSE:IMMImmupharma Plc
      03/20/20173:01AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      03/10/201711:00AMAlliance NewsAlliance NewsUPDATE: ImmuPharma Raises GBP4.1 Million, Seeks Partners For Lupuzor (ALLISS)LSE:IMMImmupharma Plc
      03/10/201710:52AMUK RegulatoryImmupharma PLC £4.1 Million Fund Raise via Accelerated BookbuildLSE:IMMImmupharma Plc
      03/10/20174:54AMAlliance NewsAlliance NewsImmuPharma To Raise GBP3 Million As It Seeks Partners For Lupuzor (ALLISS)LSE:IMMImmupharma Plc
      03/10/20172:00AMUK RegulatoryImmupharma PLC Accelerated Bookbuild for the Issue of EquityLSE:IMMImmupharma Plc
      03/06/201710:55AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      02/17/20179:04AMUK RegulatoryImmupharma PLC Holding(s) in CompanyLSE:IMMImmupharma Plc
      01/25/20176:22AMPR Newswire (US)ImmuPharma PLC: Update on Lupuzor™ Pivotal Phase III Study Full Analysis of Patient RecruitmentLSE:IMMImmupharma Plc
      01/25/20175:57AMAlliance NewsAlliance NewsImmuPharma To Report Top-Line Results From Lupuzor Trial In Early 2018LSE:IMMImmupharma Plc
       Showing the most relevant articles for your search:LSE:IMM